NeoGenomics NEO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$108.03M-37.2% | -$78.73M+10.5% | -$87.97M+39.0% | -$144.25M-1,628% | ||
| $36.07M-7.7% | $39.1M+4.4% | $37.45M+5.9% | $35.37M+17.2% | ||
| $41.32M+65.6% | $24.94M+42.9% | $17.45M-29.3% | $24.67M+9.9% | ||
| —— | $3.07M-72.6% | $11.19M-30.5% | $16.1M+156% | ||
| $6.18M-69.4% | $20.2M— | —— | —— | ||
| —— | $2.7M— | —— | $1.1M— | ||
| -$4.69M-17.2% | -$4M+12.0% | -$4.55M-575% | $958K— | ||
| —— | —— | $13.02M— | —— | ||
| -$1.56M-123% | $6.83M— | —— | —— | ||
| -$323K— | —— | $186K— | —— | ||
| $31.75M-5.1% | $33.45M-4.8% | $35.13M+3.2% | $34.06M+47.1% | ||
| —— | -$6M+21.3% | -$7.62M+10.9% | -$8.56M-8.7% | ||
| $5.23M— | —— | —— | -$65.99M-147% | ||
| $27.01M-34.2% | $41.06M+42.8% | $28.75M-6.9% | $30.89M-51.8% | ||
| $20.06M-62.8% | $53.92M-52.0% | $112.22M-4.0% | $116.92M+85.7% | ||
| -$12.34M— | —— | $76.71M— | —— | ||
| $962K-79.3% | $4.65M+0.5% | $4.62M-63.3% | $12.59M-16.5% | ||
| —— | $4.65M+2.0% | $4.55M-61.5% | $11.83M-98.4% | ||
| -$216.79M-984% | $24.52M-69.1% | $79.31M+248% | -$53.65M— | ||
| $1.69M-55.8% | $3.83M+13.3% | $3.38M-0.7% | $3.4M+11.1% | ||
| $515K— | —— | —— | $180K+20.8% | ||
| $31.75M-5.1% | $33.45M-4.8% | $35.13M+3.2% | $34.06M+47.1% | ||
| $36.07M-7.7% | $39.1M+4.4% | $37.45M+5.9% | $35.37M+17.2% | ||
| -$4.69M-17.2% | -$4M+12.0% | -$4.55M-575% | $958K— | ||
| —— | $3.07M-72.6% | $11.19M-30.5% | $16.1M+156% | ||
| —— | -$6M+21.3% | -$7.62M+10.9% | -$8.56M-8.7% | ||
| -$1.56M-123% | $6.83M— | —— | —— | ||
| $500K— | $0— | $0— | —— | ||
| $20.06M-62.8% | $53.92M-52.0% | $112.22M-4.0% | $116.92M— | ||
| —— | —— | —— | —— | ||
| $30K+115% | -$194K— | $0— | —— | ||
| —— | -$6M+21.3% | -$7.62M+10.9% | -$8.56M-8.7% | ||
| $6.75M-24.4% | $8.93M-3.3% | $9.24M-5.5% | $9.78M+12.2% | ||
| $2.07M— | $0— | $0— | —— | ||
| $6.4M+937% | $617K-91.8% | $7.52M— | —— | ||
| $515K— | —— | —— | $180K+20.8% | ||
| —— | -$34.85M— | —— | -$96.88M-6.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does NeoGenomics generate?
- NeoGenomics (NEO) generated $22.4M in operating cash flow over the trailing twelve months.
- What is NeoGenomics's free cash flow?
- After $27.5M of capital expenditures, NeoGenomics's free cash flow was -$51.3M over the trailing twelve months, down 19.8% year over year.
- Where does NeoGenomics's cash flow data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
